<DOC>
	<DOCNO>NCT01216956</DOCNO>
	<brief_summary>Nicotinic acid ( Niacin ) use many year treatment dyslipidemia . Indeed Niacin decrease triglyceride ( TG ) low density lipoprotein cholesterol ( LDL-c ) importantly increase high density lipoprotein cholesterol ( HDL-c ) . Although drug use long , precise mechanism action remain elusive . The aim study characterise metabolic change induce 8 week treatment Niacin dyslipidemic , overweight patient . The importance inhibition lipolysis overall lipid effect niacin study . In order get comprehensive view metabolic activity niacin , study investigate potential effect niacin Glucose metabolism , lipid lipoprotein turnover , quantitative change lipoproteins key enzyme involve lipid metabolism .</brief_summary>
	<brief_title>Metabolic Effects 8 Week Niaspan Treatment Patients With Abdominal Obesity Mixed Dyslipidemia</brief_title>
	<detailed_description>24 patient include double blind placebo control cross-over 8 week study compare placebo Niaspan ( long release formulation niacin ) . In order prevent drop link flushing side effect niacin , patient take aspirin ( 300mg ) prior treatment throughout study duration . The study include start end arm , full lipoproteins quantification well measure enzymes involve lipid metabolism . On day 42 56 period , administration either placebo 500mg immediate release niacin respectively , change plasma free fatty acid level measure 8hours order assess potential loss activity niacin time upon chronic treatment niaspan . Half patient exploration glucose metabolism use hyperinsulinic clamp technique , whereas half metabolic turnover study use stable isotope focus lipoprotein , triglyceride cholesterol handle . These exploration do end treatment period .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Waist circumference &gt; 94cm Triglyceride concentration 150mg/dL 400mg/dL HDLc &lt; 60mg/dL Body mass index : 27 35 kg/mÂ² cancer diabetes mellitus hepatic , renal digestive disorder hypertension chronic medical treatment interfere lipid parameter</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>extended release nicotinic acid</keyword>
	<keyword>non esterify fatty acid ( NEFA )</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>Cholesteryl ester transfer protein ( CETP )</keyword>
	<keyword>High density lipoprotein cholesterol</keyword>
</DOC>